Over-the-counter pain relievers like ibuprofen and acetaminophen are generally safe to take with Suboxone and form the backbone of pain management for people on this medication. The challenge arises because Suboxone contains buprenorphine, which binds tightly to the same receptors that most prescription painkillers target, making traditional opioid-based pain relief far less effective. That tight binding also means some drug combinations, particularly benzodiazepines, carry serious overdose risks. The full picture involves a range of options from familiar drugstore medications to specialized techniques used in hospital settings.
Why Suboxone Complicates Pain Relief
Suboxone is a combination of buprenorphine and naloxone, prescribed primarily for opioid use disorder. Buprenorphine activates opioid receptors in the brain, but only partially. It latches on with unusually high affinity, meaning it grips those receptors tightly and is difficult to displace.1Journal of Neuroscience. Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization When someone on Suboxone takes a standard opioid painkiller like oxycodone or hydrocodone, the buprenorphine already sitting on the receptors blocks much of the additional opioid from getting through. The result is that normal doses of full opioid painkillers provide far less relief than they would in someone not taking Suboxone.
There is an upside to this pharmacology. Buprenorphine shows a ceiling effect for respiratory depression, the dangerous breathing slowdown that kills people during opioid overdoses, while its pain-relieving effect continues to increase at higher doses.2PubMed. Buprenorphine induces ceiling in respiratory depression but not in analgesia This makes buprenorphine itself safer than full opioids in many respects, but it does not solve the problem of what to do when you need more pain relief on top of it.
Over-the-Counter Pain Medications
The simplest and safest category is non-opioid pain relievers you can buy without a prescription. These work through entirely different mechanisms than opioids, so buprenorphine’s receptor-hogging behavior does not interfere with them at all.
- NSAIDs: Ibuprofen (Advil, Motrin) and naproxen (Aleve) reduce inflammation and are effective for many types of pain including headaches, muscle aches, joint pain, and menstrual cramps. They work by blocking enzymes involved in the inflammatory process, which has nothing to do with opioid receptors.
- Acetaminophen: Tylenol works through a different pathway than NSAIDs and is useful for pain and fever. It can be combined with an NSAID for more relief than either alone, and this combination is a first-line recommendation for people on buprenorphine who need pain management.
These medications carry their own risks, of course. NSAIDs can irritate the stomach lining and are not ideal for people with kidney problems, while acetaminophen can damage the liver at high doses. But none of these risks are made worse by Suboxone. They can be used at standard doses just as they would be for anyone else.
The Multimodal Strategy
Clinical practice has shifted strongly toward what is called multimodal pain management for people on buprenorphine. Instead of relying on a single strong painkiller, this approach layers several different types of relief. A review of the evidence found that adequate pain control can be achieved while keeping someone on their buprenorphine, using a combination of opioid and non-opioid options for breakthrough pain.3PubMed Central. Treating Perioperative and Acute Pain in Patients on Buprenorphine: Narrative Literature Review and Practice Recommendations The key recommendations from that review were to continue buprenorphine during pain episodes rather than stopping it, use multiple types of pain relief simultaneously, coordinate carefully around discharge planning, and individualize the approach through shared decision-making with the patient.
This matters because stopping Suboxone to allow traditional opioid painkillers to work puts people at serious risk of relapse. The older approach of discontinuing buprenorphine before surgery or during a pain crisis has fallen out of favor precisely because the relapse risk outweighs the modest gain in opioid-based pain relief.
Gabapentin and Pregabalin
Gabapentin (Neurontin) and pregabalin (Lyrica) are commonly prescribed alongside Suboxone, especially for nerve-related pain. A large study looking at gabapentin use among people starting buprenorphine treatment found that days of gabapentin use were not associated with hospitalization for drug-related poisoning, and the risk did not vary based on dosage.4JAMA Network. Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder From a poisoning standpoint, gabapentin prescribed at therapeutic doses did not appear to increase acute danger when combined with buprenorphine.
However, gabapentinoids show up frequently in a different and more alarming context. In an analysis of buprenorphine-related deaths, gabapentinoids were found in half of all cases.5Drug and Alcohol Dependence. Concomitant drugs with buprenorphine user deaths The critical detail is that these deaths almost always involved other central nervous system depressants as well, particularly benzodiazepines, which were present in the vast majority of fatal cases. So the picture with gabapentin is that prescribed use at normal doses appears relatively safe, but misuse or combination with sedatives like benzodiazepines significantly raises the danger. If your doctor has prescribed gabapentin alongside Suboxone, the prescription itself is not the concern. The risk comes from mixing it with other sedating substances.
Benzodiazepines and the Biggest Risk
If there is one class of medication to treat with extreme caution while on Suboxone, it is benzodiazepines. Drugs like alprazolam (Xanax), diazepam (Valium), and clonazepam (Klonopin) are prescribed for anxiety and insomnia, but they carry a sharply elevated risk when combined with buprenorphine. A study following people receiving buprenorphine treatment found that those who also received benzodiazepine prescriptions had roughly triple the risk of fatal opioid overdose and about double the risk of non-fatal overdose.6PubMed Central. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine
The death data reinforces this starkly. In buprenorphine poisoning deaths, benzodiazepines were present in 94% of cases, with clonazepam alone found in over half.5Drug and Alcohol Dependence. Concomitant drugs with buprenorphine user deaths Only three deaths in that analysis occurred without benzodiazepines, alcohol, or gabapentinoids being involved. Both buprenorphine and benzodiazepines depress the central nervous system, and their combined sedating effects on breathing are what make the pairing so dangerous.
This does not mean benzodiazepines are never prescribed to people on Suboxone. Some people have severe anxiety disorders that genuinely require them. But when they are co-prescribed, it should involve careful dose management and close monitoring. If you are on Suboxone and experiencing anxiety or insomnia, non-benzodiazepine options like SSRIs, buspirone, or hydroxyzine are worth discussing with your prescriber first.
Handling Surgical Pain and Acute Injuries
Surgery and acute injuries represent the hardest pain-management scenario for someone on Suboxone, because these situations often produce pain that over-the-counter medications cannot fully address. The evidence-based approach now favors continuing buprenorphine through the perioperative period rather than stopping it.3PubMed Central. Treating Perioperative and Acute Pain in Patients on Buprenorphine: Narrative Literature Review and Practice Recommendations One case report from a protocol at a major medical center demonstrated successful pain control and timely discharge for a patient who continued Suboxone through ambulatory surgery.7PubMed Central. Perioperative Management of a Patient Taking Suboxone® at the Time of Ambulatory Surgery
When buprenorphine alone is not enough, surgeons and anesthesiologists layer on additional strategies. Regional anesthesia, where numbing medication is injected near specific nerves to block pain from a defined area of the body, is especially valuable because it bypasses the opioid receptor problem entirely. A case-based learning module described using regional anesthesia combined with ketamine to achieve effective surgical pain control while the patient stayed on their baseline buprenorphine.8PubMed Central. Managing Acute Surgical Pain in Patients on Buprenorphine: A Case-Based Learning Module Ketamine works on a completely different receptor system than opioids and can be a powerful addition for severe pain in this population.
If you know you are going to have surgery, the most important step is telling your surgical team and anesthesiologist that you take Suboxone well before the procedure. Many hospitals now have protocols specifically for this situation, but those protocols only help if the team knows about your medication in advance. Surprising your surgical team on the day of the procedure limits their options significantly.
Some Medications That Interact Indirectly
Buprenorphine is primarily broken down by a liver enzyme called CYP3A4. Medications that speed up or slow down this enzyme can change how much buprenorphine is in your system, which matters for both its maintenance effects and its role in pain management.
Strong inhibitors of CYP3A4, which include certain antifungal medications (like ketoconazole) and some HIV antivirals, can raise buprenorphine levels modestly. However, modeling studies of an extended-release buprenorphine formulation predicted that these increases would be mild, in the range of a third to 44% increase in overall drug exposure, and were not considered clinically meaningful.9PubMed Central. Evaluation of Drug‐Drug Interaction Liability for Buprenorphine Extended‐Release Monthly Injection Administered by Subcutaneous Route For the injectable form, this interaction is largely absorbed by the slow-release design.
The interaction is more relevant with the sublingual formulation. Rifampicin, a strong CYP3A4 inducer used to treat tuberculosis, reduced sublingual buprenorphine exposure by about a quarter in healthy volunteers, enough to potentially compromise its pain-relieving effect.10PubMed Central. Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects The sublingual route already has relatively low bioavailability because the drug partially passes through the liver before reaching the bloodstream, and a CYP3A4 inducer makes that first-pass metabolism even more aggressive. If you are taking any medication for tuberculosis, HIV, or fungal infections, your Suboxone prescriber should know.
Muscle Relaxants and Other Adjuncts
Muscle relaxants like cyclobenzaprine (Flexeril), baclofen, and tizanidine are sometimes prescribed for musculoskeletal pain. These are not opioids, so they do not compete with buprenorphine at the receptor level. However, many muscle relaxants have sedating effects, and combining multiple sedating medications always warrants caution. Research on concurrent use of muscle relaxants with opioids (not buprenorphine specifically) has shown variable risk depending on the specific combination, with some pairings increasing injury risk and others appearing neutral or even protective.11PubMed Central. Comparative Risk of Injury with Concurrent Use of Opioids and Skeletal Muscle Relaxants Because buprenorphine has a ceiling on respiratory depression that full opioids do not, the risk profile is likely different, but the general principle of being cautious with stacking sedatives still applies.
Topical pain relief is another underappreciated option. Lidocaine patches, diclofenac gel, and capsaicin cream all deliver pain relief locally without significant systemic absorption, meaning they do not interact with Suboxone in any meaningful way. For localized pain from arthritis, sprains, or minor injuries, topical agents let you treat the problem area directly without adding anything to the mix of medications your liver has to process.
Non-pharmacological approaches also deserve mention because they can meaningfully reduce medication needs. Ice and heat therapy, physical therapy, transcutaneous electrical nerve stimulation (TENS), and cognitive behavioral therapy for pain management are all tools that work independently of opioid receptors. For people on Suboxone dealing with chronic pain, these approaches can reduce the need for additional medications and are worth pursuing alongside any drug-based strategy.
Pain Management During Pregnancy and Postpartum
People who become pregnant while on buprenorphine face a unique version of this question, particularly around delivery. A study of postpartum pain management found that routine pain protocols were effective at reducing pain for women maintained on buprenorphine during pregnancy after a vaginal delivery, though most opioid-dependent patients required higher than typical doses for adequate pain control.12PubMed Central. Management of Acute Postpartum Pain in Patients Maintained on Methadone or Buprenorphine During Pregnancy Pain control also appeared to depend on which maintenance medication the patient was using.
The standard approach for postpartum pain in this population relies on the same multimodal principle: NSAIDs and acetaminophen as the foundation, with additional interventions layered as needed. Buprenorphine is generally continued through pregnancy and the postpartum period because the risks of discontinuation, including relapse and its consequences for both parent and infant, outweigh the pain management challenges it creates. The message from the evidence is that pain can be managed effectively, but it requires individualized dosing and close communication between the obstetric team and the addiction medicine provider.
What Precipitated Withdrawal Looks Like and Why It Matters
One scenario that occasionally arises in pain management is precipitated withdrawal. This happens when buprenorphine is introduced while another opioid is still active in the body, but it can also become relevant in reverse: if someone on Suboxone is given a full opioid agonist in a pain crisis and then their buprenorphine reasserts dominance as the short-acting opioid wears off. Precipitated withdrawal involves a rapid onset of symptoms including aches, nausea, vomiting, diarrhea, dilated pupils, and a running nose, typically within one to two hours, gradually subsiding over six to 24 hours.13PubMed Central. Managing opioid withdrawal precipitated by buprenorphine with buprenorphine This has been reported in about 9% of buprenorphine inductions, with risk factors including transfer from longer-acting opioids like methadone and recent benzodiazepine use.
For pain management purposes, this means that the transitions around Suboxone need careful timing. If a medical team decides to temporarily use a full opioid agonist for severe pain, restarting buprenorphine too soon afterward can trigger precipitated withdrawal. Conversely, if someone stops their buprenorphine and uses full opioids for pain, the return to Suboxone requires waiting until the full opioid has cleared sufficiently. These transitions are precisely why the current guidance favors continuing buprenorphine and supplementing with non-opioid strategies rather than stopping and switching.
Common Misconceptions About Pain and Suboxone
One of the most persistent misunderstandings is that people on Suboxone cannot feel pain or do not need pain treatment. Buprenorphine provides some baseline pain relief through its partial activation of opioid receptors, but it is not a complete analgesic at the doses used for opioid use disorder maintenance. Dental procedures, injuries, and post-surgical pain are all real and require treatment. Dismissing a Suboxone patient’s pain because “they’re already on an opioid” reflects a misunderstanding of how partial agonism works.
Another misconception runs in the opposite direction: that nothing can touch the pain while someone is on Suboxone, so why bother. The evidence consistently shows that multimodal approaches work. Combining NSAIDs, acetaminophen, regional anesthesia, and adjuncts like ketamine or gabapentin can produce effective relief without needing to overcome buprenorphine’s receptor binding.8PubMed Central. Managing Acute Surgical Pain in Patients on Buprenorphine: A Case-Based Learning Module The problem is not that pain cannot be managed; it is that managing it well requires a plan and a team that understands the pharmacology involved.
A third misconception is that you should stop Suboxone before any painful procedure. Earlier surgical guidelines sometimes recommended this, but the practice has been increasingly abandoned. Stopping buprenorphine exposes people to withdrawal, cravings, and the risk of returning to illicit opioid use, and the window of full opioid use that follows can itself become dangerous. The evidence now supports continuing buprenorphine and building the pain plan around it rather than removing the safety net to make traditional painkillers work slightly better.3PubMed Central. Treating Perioperative and Acute Pain in Patients on Buprenorphine: Narrative Literature Review and Practice Recommendations